#5e2d92_SMALL_Nov-Dec 2024 DRA Journal Cover

From myth-busting photobiomodulation therapy to showcasing advanced aesthetic cases, this issue delivers practical insights for modern dental practice. Explore evidence-based techniques in implant and veneer rehabilitation, essential guidance on monkeypox protocols, and strategies for enhanced patient communication.

>> FlipBook Version (Available in English)

>> Mobile-Friendly Version (Available in Multiple Languages)

Click here to access Asia's first Open-Access, Multi-Language Dental Publication

HPV Vaccination Uptake Initiative Piloted in Dental Clinics

Dental professionals have an opportunity to contribute to cancer prevention by identifying patients eligible for the human papillomavirus (HPV) vaccine during routine dental visits. A recent study conducted in Edmonton, Alberta, Canada, explored the feasibility of implementing a case-finding strategy and dialogue tool to facilitate discussions about HPV vaccination within dental practices.

There is a concerning upward trend of HPV-associated oropharyngeal cancer, which the authors highlight as a motivation for their research. As one of the authors, Cheryl E. Cable, states, “There is a concerning upward trend of HPV-associated oropharyngeal cancer in our society.”

The Study

The study involved a prospective, non-randomized feasibility case-finding approach. Over a 4-week enrollment period, consecutive scheduled patients aged 9-45 years (or immunocompromised individuals) were screened for HPV vaccination eligibility at two general dental offices in Edmonton. Dental clinicians used a Dental Dialogue Tool to discuss HPV vaccination and answer questions with eligible patients who consented to the discussion. Patients who agreed to receive the vaccine were given a prescription and directed to follow up with a local pharmacy.

The Findings

The case-finding strategy assessed 656 scheduled patients, identifying 179 (20.4%) as candidates for HPV vaccine discussion. Of these, 43 (24%) were already vaccinated, and 134 (74.8%) consented to the discussion. Forty-eight patients (35.8%) accepted a prescription from the dentist after the discussion.

However, only 8 of the 48 patients (16%) who received a prescription had received their first dose of the HPV vaccine by the 6-week follow-up call. This translates to a modest 4.5% of those who initially consented to the discussion.

The study demonstrated the feasibility of case-finding for HPV vaccine candidates in general dental offices, with a reasonable yield. While the dental dialogue tool was described as a valuable resource, the authors acknowledge that further work is necessary to enhance the intervention’s effectiveness, potentially including follow-up discussions with dental clinicians.

As Kaitlyn E. Watson, one of the authors, notes, “Dental professionals already screen for oral cancers and have a unique opportunity to help prevent oropharyngeal cancers by proactively discussing with their patients about cancer risk and by recommending HPV vaccination.”

The information and viewpoints presented in the above news piece or article do not necessarily reflect the official stance or policy of Dental Resource Asia or the DRA Journal. While we strive to ensure the accuracy of our content, Dental Resource Asia (DRA) or DRA Journal cannot guarantee the constant correctness, comprehensiveness, or timeliness of all the information contained within this website or journal.

Please be aware that all product details, product specifications, and data on this website or journal may be modified without prior notice in order to enhance reliability, functionality, design, or for other reasons.

The content contributed by our bloggers or authors represents their personal opinions and is not intended to defame or discredit any religion, ethnic group, club, organisation, company, individual, or any entity or individual.

Leave a Reply

Your email address will not be published. Required fields are marked *